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Introduction: Thrombocytopenia is a common hematologic abnormality during pregnancy. 
Pregnant women with thrombocytopenia have a higher risk of bleeding excessively during or 
after childbirth, particularly if they need to have a cesarean section or other surgical interven-
tion during pregnancy, labor or in the puerperium. The main aim of this study was to determine 
the prevalence of thrombocytopenia among pregnant women attending antenatal care service 
at Gondar University Hospital, northwest Ethiopia.
Materials and methods: A cross-sectional study was used to assess the prevalence of throm-
bocytopenia among pregnant women attending antenatal care service at Gondar University 
Hospital from January to April 2015. A total of 217 pregnant women were included in the study 
and a structured pretested questionnaire was used to obtain sociodemographic information, 
nutritional factors, obstetrics and gynecological factors, history and clinical condition. Blood 
samples were collected for platelet count and other platelet parameters, which were determined 
by using SysmexKX 21 automation. The data were entered to Epi info version 6 software and 
analyzed using SPSS version 20 software. Bivariable and multivariable statistical analyses were 
used to evaluate the effect of independent variable over the dependent variable. A p-value of 
<0.05 was considered as statistically significant.
Result: A total of 217 women receiving antenatal care service at Gondar University Hospital 
participated in the study. Thrombocytopenia among 19 pregnant women showed a prevalence 
of 8.8%. The mean ± standard deviation platelet count was 238.85×109/L (±74.57). Thrombo-
cytopenia was significantly associated with patients who lived rurally (crude odds ratio =4.3, 
95% confidence interval 1.48–12.76).
Conclusion: The prevalence of thrombocytopenia was 8.8% predominantly with mild type of 
thrombocytopenia. Thrombocytopenia was higher among pregnant women who lived rurally. 
Therefore, health care providers should screen routinely for thrombocytopenia to avoid exces-
sive bleeding during pregnancy, especially in women who live rurally.
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Introduction
Platelets are nonnucleated blood cells formed by cellular fragments of megakaryo-
cytes, and they have a critical role in maintaining hemostasis.1 Thrombocytopenia 
is suspected when a patient’s platelet count is <150,000×103/mm3. The normal 
reference range for platelet count in a nonpregnant woman is 150,000–400,000× 
103/mm3. Due to hemodilution secondary to expansion of plasma volume, platelet count 
in  normal pregnancies may be decreased by ~10%; most of the decrease in platelet 
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count occurs during the third trimester of pregnancy,2–5 
although the absolute platelet count remains within normal 
reference range in most patients.3,6 Thrombocytopenia can 
be classified as mild (platelet count of 100,000–150,000× 
103/mm3), moderate (platelet count of 50,000–100,000× 
103/mm3) or severe (platelet count <50,000×103/mm3).1
During pregnancy, most cases of low platelet count 
are due to gestational thrombocytopenia (GT), idiopathic 
thrombocytopenic purpura (ITP) or preeclampsia.7 Other 
causes include infection, such as malaria or folate defi-
ciency, and diseases, such as leukemia and aplastic anemia.4 
GT is characterized by incidental detection of mild-to-
moderate reduction in platelet count during pregnancy in 
otherwise healthy women with no previous history of ITP or 
conditions known to be associated with thrombocytopenia. 
It is not an early manifestation of autoimmune disease, there 
is no significant fetal or maternal morbidity, and normaliza-
tion of platelet counts occur in the vast majority of patients 
postpartum.7–10 GT is responsible for ~75% of thrombocy-
topenia in pregnant women.7 GT is usually mild and is not 
usually associated with fetal thrombocytopenia.11 Platelet 
count in patients with GT is usually >110,000×103/mm3, 
whereas counts as low as 70,000×103/mm3 have been 
reported. In patients with platelet count <70,000×103/mm3, 
an alternative explanation is frequently present. Although 
the pathogenesis of GT is not well understood, it may 
involve factors such as hemodilution and/or accelerated 
platelet clearance.12,13 It is known that pregnant women with 
thrombocytopenia have a higher risk of bleeding exces-
sively during or after childbirth, particularly if they need 
to have a cesarean section or other surgical intervention 
during pregnancy or labor. Such bleeding complications 
are more likely when the platelet count is <50×103/mm3.1
Thrombocytopenia during pregnancy has become a 
cause for unnecessary, often invasive, additional testing 
and cesarean deliveries. The evaluation and treatment 
of this condition can be expensive and distressing to the 
patient and can result in an adverse outcome. Obstetricians 
in our locality have no comprehensible guide for manag-
ing pregnant women with thrombocytopenia due to a lack 
of data about the frequency, severity and causes of this 
condition. Moreover, no relevant data are available from 
other parts of Ethiopia. Therefore, this study was aimed at 
determining the prevalence of thrombocytopenia among 
pregnant women attending antenatal care service at Gondar 
University Hospital, and estimating the proportions of the 
underlying causes that can give valuable information for the 
management of thrombocytopenia-related complications in 
pregnant women.
Materials and methods 
Study settings and study population
An institutional-based cross-sectional study design was used 
to assess the prevalence of thrombocytopenia among preg-
nant women attending the antenatal care service at Gondar 
University Hospital from January to April 2015. All women 
between the ages of 15–49 years who visited Gondar Uni-
versity Hospital for antenatal care during the study period 
were the source population.
Data collection
Women who visited the antenatal care unit at Gondar Univer-
sity Hospital during the study period participated in the study. 
Pregnant women on anti-inflammatory drugs, had a bleeding 
disorder, splenomegaly, or hypertension, or were on antiretro-
viral treatment were excluded from the study. After obtaining 
written informed consent, sociodemographic nutritional factors, 
obstetrics and gynecological factors, history and clinical condi-
tion were collected from each study participant using a pretested 
structured questionnaire, those who had normal blood pressure, 
were free from malaria parasites and had no platelet aggrega-
tion on peripheral film examination were included in the study.
Two milliliters of venous blood was collected under aseptic 
conditions and transferred in to ethylene diamine tetra acetic 
acid (EDTA) anticoagulant tubes by mixing for 5 minutes. 
The specimens were labeled with identification number of 
each study participant. The EDTA anticoagulant specimens 
were kept at room temperature until analysis was done for a 
maximum of 4 hours after specimen collection. The complete 
blood cell counts were determined using SysmexKX 21 
analyzer (Sysmex Corporation, Bellport, NY, USA) which 
applies electric impedance principle (Sysmex user manual, 
2002) following the manufacturer’s instructions.
The reliability of the study findings was guaranteed by 
implementing quality control (QC) measures throughout 
the whole process of the laboratory work. All materials, 
equipment and procedures were adequately controlled. Sys-
mex were checked for linearity and validity by using lower, 
medium and high quality control reagents. Preanalytical, 
analytical and postanalytical stages of quality assurance that 
were incorporated in standard operating procedures were 
strictly followed. Appropriate volume of blood and antico-
agulant was used to maintain the specimen’s quality. Every 
day before the samples were investigated, control reagents 
with low, medium and high concentration were simultane-
ously investigated by the Sysmex machines to maintain the 
reagents quality. In addition, thin blood films stained with 
Wright stain were prepared for all blood samples, to  confirm 
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thrombocytopenia and exclude the presence of platelet aggre-
gation and malaria parasites.
Data processing
The data were entered, cleaned and analyzed using SPSS 
statistical computer software version 20 (IBM Corporation, 
Armonk, NY, USA). Summary statistics such as frequen-
cies and percentages were calculated. Logistic regression 
was used to identify the associated factors with thrombo-
cytopenia. A 95% confidence interval and a p-value <0.05 
were considered as statistically significant. 
Ethical approval
Ethical approval was obtained from the University of 
Gondar, School of Biomedical and Laboratory Sciences 
Ethical Clearance Committee, and a permission letter was 
obtained from Gondar University Hospital Chief Execu-
tive Officer before going ahead with the study. Each study 
participant were asked to participate voluntarily and pro-
vided written informed consent  to participate in the study. 
Parental consent was obtained for participants <16 years 
of age. Confidentiality was kept throughout the collec-
tion and processing of specimens. Each study participant 
were informed about the objective of the study. Voluntary 
participation and the right to withdraw at any time were 
emphasized. In addition to this, any study subject with an 
abnormal test result were referred to their physicians for 
further investigation and management.
Results
Sociodemographic characteristics of 
study participants
In this study, a total of 217 woman from the antenatal care at 
Gondar University Hospital were included in this study. One 
hundred and sixty-nine (77.8%) of the study subjects were aged 
<30 years. The mean (± standard deviation [SD]) age of the 
study participants were 25.67 (±4.69) years. Most of the study 
subjects (192 [88.3%]) lived in an urban residence. Among the 
study subjects, 215 (99.1%) were married and 137 (63.1%) 
were housewives by occupation. Among the study subjects, 
35 (16.1%) were unable to read and write (illiterate; Table 1).
Reproductive characteristics of pregnant 
women attending antenatal care at 
Gondar University Hospital in 2014, 
northwest Ethiopia
Among the study subjects, 38.2%, 36.9% and 24.9% were 
in the third, second and first trimester, respectively. The 
mean number of children that the women had were 2, with 
2.3% having only one child and 47% having three and more 
children (Table 2).
Table 1 Sociodemographic characteristics of pregnant women 
attending antenatal care service at Gondar University Hospital in 
2014, northwest Ethiopia
Sociodemographic variables Frequency (%) 
Age category (years)
 15–19 16 (7.4)
 20–24 69 (31.8)
 25–29 84 (38.7)
 30–34 31 (14.3)
 35–39 17 (7.8)
Place of residence
 Urban 192 (88.5)
 Rural 25 (11.5)
Occupation
 Housewife 137 (63.1)
 Privately employed 21 (9.7)
 Government employed 48 (22.1)
 Student 11 (5.1)
Educational status
 Unable to read and write 35 (16.1)
 Primary school 50 (23.0)
 Secondary school 73 (33.6)
 Tertiary 59 (27.2)
Marital status
 Single 2 (0.9)
 Married 215 (99.1)
Table 2 Reproductive characteristics of pregnant women 
attending antenatal care service at Gondar University Hospital in 
2014, northwest Ethiopia
 Reproductive characteristics Frequency (%) 
Gestational stage
 First trimester 54 (24.9)
 Second trimester 80 (36.9)
 Third trimester 83 (38.2)
Number of children
 One 5 (2.3)
 Two 110 (50.7)
 Three 36 (16.6)
 Four or more 66 (30.4)
History of abortion
 Yes 19 (8.8)
 No 198 (91.2)
Vaginal bleeding
 Yes 4 (1.8)
 No 213 (98.2)
Take iron and folic acid supplement
 Yes 182 (83.9)
 No 35 (16.1)
Have tea or coffee immediately after meal
 Yes 145 (66.8)
 No 72 (33.2)
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Hematological profiles of the study 
subjects
The mean (± SD) hematologic profiles of the study subjects 
were platelet count 238.85+74.57×109/L, white blood cell 
(WBC) count 9.35+2.85×109/L and red blood cell (RBC) 
count 4.43+0.40×1012/L (Table 3).
Table 3 Hematologic profiles of pregnant women attending antenatal care service at Gondar University Hospital in 2014, northwest 
Ethiopia
Hematologic profiles Mean SD Minimum Maximum
Total WBC 9.35×103/mm3 2.85×103/mm3 3.50×103/mm3 17.40×103/mm3
Lymphocyte 2.29×103/mm3 0.54×103/mm3 0.70×103/mm3 4.20×103/mm3
Monocyte 0.84×103/mm3 0.54×103/mm3 0.30×103/mm3 7.70×103/mm3
Neutrophils 6.26×103/mm3 2.46×103/mm3 1.30×103/mm3 13.70×103/mm3
RBC 4.43×106/mm3 0.40×106/mm3 2.77×106/mm3 5.41×106/mm3
Hgb, g/dL 13.15 1.07 7.00 16.40
HCT, % 41.29 3.52 24.80 52.40
MCV, fL 93.46 4.77 81.50 118.40
MCH, pg 29.75 1.99 24.40 41.60
MCHC, g/dL 31.85 1.36 28.20 41.20
RDW, fL 14.42 1.78 11.90 32.40
PLT 238.85×103/mm3 74.57×103/mm3 49.00×103/mm3 447.00×103/mm3
Abbreviations: HCT, hematocrit; Hgb, hemoglobin; MCH, mean cell hemoglobin; MCHC, mean cell hemoglobin concentration; MCV, mean cell volume; PLT, platelet; RBC, 
red blood cell; RDW, red cell distribution width; SD, standard deviation; WBC, white blood cell.
Figure 1 Severity of thrombocytopenia among pregnant women.
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Prevalence of thrombocytopenia
The prevalence of thrombocytopenia in this study was found 
in 19 women (8.8%), the remaining 198 (92.2%) women 
had a platelet count in the normal range. Among the throm-
bocytopenic pregnant women in this study, 74% had mild 
thrombocytopenia, 15.7% had moderate thrombocytopenia 
and 10.3% had severe thrombocytopenia (Figures 1 and 2).
Factors associated with thrombocytopenia
Factors associated with thrombocytopenia were assessed by 
logistic regression and showed that living in a rural residence 
showed women were approximately four times more likely 
to develop thrombocytopenia than women living in an urban 
area (crude odds ratio [COR]=4.35, 95% confidence interval 
1.48–12.76) (Table 4).
Discussion
This study was conducted in order to determine the prevalence 
of thrombocytopenia among pregnant women attending the 
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 antenatal care at Gondar University Hospital. In this study, 
the prevalence of thrombocytopenia among pregnant women 
was 8.8%. In this study, the prevalence of thrombocytope-
nia among pregnant women was 8.8%, which was almost 
comparable to the results of studies conducted by Vyas 
et al14 (7.67%), Nisha et al15 (8.8%), Dwivedil16 (8.17%), 
Shamoon et al17 (8%), Myers18 literature review (8%–10%), 
Jeffrey et al19 clinical review (8%), and Jodkowska et al20 
(7%–10%). However, the result of this study was lower than 
in studies conducted in Switzerland (11.6%),21 Ethiopia 
(13.5%),22 Ghana (15.3%),23 Israel (21.8%),24 and Nigeria 
(13.5%).25 The difference may be due to sociodemographic 
differences of the study subjects and differences in the study 
design. Among the thrombocytopenic pregnant women in our 
study, 74% had mild thrombocytopenia, 15.7% had moderate 
thrombocytopenia and 10.3% had severe thrombocytopenia. 
These results are in line with studies conducted in Ethiopia, 
Ghana, India and Nigeria14,22,23,25,26 which showed a high fre-
quency presence of mild type thrombocytopenia. This study 
showed that there was no association between the trimesters 
and thrombocytopenia (p>0.05). This result is similar with 
previous studies conducted in Ethiopia.22
In summary, thrombocytopenia is a crucial problem 
among pregnant women with the prevalence of thrombocy-
topenia shown to be 8.8%, dominantly mild type thrombo-
cytopenia. Thrombocytopenia was higher among pregnant 
Table 4 Factors associated with thrombocytopenia among pregnant women attending antenatal care service at Gondar University 
Hospital in 2014, northwest Ethiopia
Variables Thrombocytopenia COR (95% CI) p-value
Yes No
Educational level 
 Illiterate 6 29 0.42 (0.109–1.618) 0.207
 Primary 4 46 0.68 (0.221–2.088) 0.50
 Secondary 9 64 1 0.99
 Tertiary 0 59 1
Iron supplement
 Yes 16 166 1
 No 3 32 1.028 (0.283–3.734) 0.966
HIV positive?
 Yes 1 18 2.14 (0.237–19.367) 0.5
 No 5 193 1
Trimester
 First 7 47 1
 Second 5 75 0.45 (0.134–1.492) 0.191
 Third 7 76 0.62 (0.204–1.875) 0.396
Residence
 Urban 13 179 1
 Rural 6 19 4.348 (1.481–12.76) 0.007
Abbreviations: CI, confidence interval; COR, crude odds ratio.
women in the study area who were from a rural residence. 
For this reason, screening of pregnant women should include 
a platelet count, especially if they reside in a rural area.
Limitation of the study
The study was a cross-sectional study and it did not include 
control groups. Since this study is not a follow-up study, it 
may lack many independent factors of thrombocytopenia 
assessment.
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